Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-18 Purchase |
2021-05-20 4:32 pm |
Marker Therapeutics Inc. | MRKR | Wasserman Frederick Gerald Director |
10,000 | $2.4098 | $24,098 | 52,565 (Direct) |
View |
| 2021-03-16 Purchase |
2021-03-18 5:18 pm |
Marker Therapeutics Inc. | MRKR | Walker Paul Edward 10% Owner |
5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) |
View |
| 2021-03-16 Purchase |
2021-03-18 5:17 pm |
Marker Therapeutics Inc. | MRKR | Sonsini Peter W. 10% Owner |
5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) |
View |
| 2021-03-16 Purchase |
2021-03-18 5:17 pm |
Marker Therapeutics Inc. | MRKR | SANDELL SCOTT D 10% Owner |
5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) |
View |
| 2021-03-16 Purchase |
2021-03-18 5:16 pm |
Marker Therapeutics Inc. | MRKR | MAKOWER JOSHUA 10% Owner |
5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) |
View |
| 2021-03-16 Purchase |
2021-03-18 5:15 pm |
Marker Therapeutics Inc. | MRKR | Makhzoumi Mohamad 10% Owner |
5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) |
View |
| 2021-03-16 Purchase |
2021-03-18 5:14 pm |
Marker Therapeutics Inc. | MRKR | Florence Anthony A. Jr. 10% Owner |
5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) |
View |
| 2021-03-16 Purchase |
2021-03-18 5:12 pm |
Marker Therapeutics Inc. | MRKR | Chang Carmen 10% Owner |
5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) |
View |
| 2021-03-16 Purchase |
2021-03-18 5:11 pm |
Marker Therapeutics Inc. | MRKR | Behbahani Ali 10% Owner |
5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) |
View |
| 2021-03-16 Purchase |
2021-03-18 5:09 pm |
Marker Therapeutics Inc. | MRKR | BASKETT FOREST 10% Owner |
5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) |
View |
| 2021-03-16 Purchase |
2021-03-18 5:08 pm |
Marker Therapeutics Inc. | MRKR | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner |
5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Direct) |
View |
| 2021-03-16 Purchase |
2021-03-18 4:39 pm |
Marker Therapeutics Inc. | MRKR | Wilson John Robert Director |
1,714,285 | $1.75 | $2,999,999 | 7,799,350 (Direct) |
View |
| 2021-03-16 Purchase |
2021-03-18 4:38 pm |
Marker Therapeutics Inc. | MRKR | Vera Juan Chief Development Officer |
571,428 | $1.75 | $999,999 | 2,564,487 (Direct) |
View |
| 2021-03-16 Purchase |
2021-03-18 4:36 pm |
Marker Therapeutics Inc. | MRKR | Hoang Peter L. President and CEO |
142,857 | $1.75 | $250,000 | 332,568 (Direct) |
View |
| 2021-03-16 Purchase |
2021-03-18 4:35 pm |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
1,142,857 | $1.75 | $2,000,000 | 3,159,879 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-08 Option Award |
2021-06-10 6:54 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Eansor Norman David Director |
12,658 | $0 | 36,940 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 6:53 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Wilson John Robert Director |
12,658 | $0 | 7,812,008 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:39 pm |
N/A 2031-02-10 |
Marker Therapeutics Inc. | MRKR | Vera Juan Chief Development Officer |
140,000 | $0 | 140,000 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:37 pm |
N/A 2031-02-10 |
Marker Therapeutics Inc. | MRKR | Szymanska Anna Vice President, Quality |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:36 pm |
N/A 2031-02-10 |
Marker Therapeutics Inc. | MRKR | Loiacono Michael Chief Accounting Officer |
140,000 | $0 | 140,000 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:34 pm |
N/A 2031-02-10 |
Marker Therapeutics Inc. | MRKR | Koneru Mythili Chief Medical Officer |
140,000 | $0 | 140,000 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:31 pm |
N/A 2031-02-10 |
Marker Therapeutics Inc. | MRKR | Kim Anthony H. Chief Financial Officer |
160,000 | $0 | 160,000 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:29 pm |
N/A 2031-02-10 |
Marker Therapeutics Inc. | MRKR | Hoang Tsvetelina P VP, Research and Development |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-12 5:26 pm |
N/A 2031-02-11 |
Marker Therapeutics Inc. | MRKR | Hoang Peter L. President and CEO |
430,000 | $0 | 430,000 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:23 pm |
N/A 2031-02-10 |
Marker Therapeutics Inc. | MRKR | Garrett Gerald Vice President, Clinical Ops. |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 5:21 pm |
N/A 2031-02-10 |
Marker Therapeutics Inc. | MRKR | Agopyan Nadia VP, Regulatory Affairs |
40,000 | $0 | 40,000 (Direct) |
View |
| 2020-05-19 Ownership |
2021-02-12 5:18 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Wilson John Robert Director |
17,022 | $0 | 6,085,065 (Direct) |
View |
| 2020-05-19 Ownership |
2021-02-12 5:17 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Wasserman Frederick Gerald Director |
17,022 | $0 | 42,565 (Direct) |
View |
| 2020-05-19 Ownership |
2021-02-12 5:13 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Laskow-Pooley David Director |
17,022 | $0 | 42,565 (Direct) |
View |
Ownership |
2021-02-12 5:12 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
0 | $0 | 2,017,022 (Indirect) |
View |
| 2020-05-19 Ownership |
2021-02-12 5:12 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | ELMS STEVE Director |
17,022 | $0 | 2,017,022 (Direct) |
View |
| 2020-05-19 Ownership |
2021-02-12 5:11 pm |
N/A N/A |
Marker Therapeutics Inc. | MRKR | Eansor Norman David Director |
17,022 | $0 | 24,282 (Direct) |
View |
| 2020-06-16 Other |
2020-06-19 07:49 am |
2015-03-09 2020-06-16 |
Marker Therapeutics Inc. | MRKR | Eastern Capital LTD Portfolio Services Ltd. DART KENNETH BRYAN 10% Owner |
416,667 | $0 | 0 (Direct) |
View |